The project, led by Assistant Professor of Biology Alicia Rogers, could lead to improved genetic knowledge that may aid in the development of synthetic therapies to prevent or treat diseases, including cancer.
UT Southwestern Medical Center and pharmaceutical company Pfizer have teamed up to develop new ways to deliver genetic treatments to patients.
Together they aim to accelerate the development of therapies that work through RNA biology and engineered delivery methods to fix root genetic causes of disease, which Pfizer could apply to its portfolio of investigational programs.
Caris Life Sciences, the Irving-based biotech company, announced Thursday that it closed a senior secured term loan providing up to $400 million in capital from OrbiMed and Braidwell, bringing its funding total since 2018 to roughly $1.7 billion....
Two North Texas startups — Rockwall-based Resolute Grid, a provider of power transformers, and Dallas-based Auger, a provider of supply-chain software — recently received awards at the Venture Dallas 2026 conference....
Two North Texas startups — Rockwall-based Resolute Grid, a provider of power transformers, and Dallas-based Auger, a provider of supply-chain software — recently received awards at the Venture Dallas 2026 conference....